Diabetes mellitus (DM) is a metabolic disorder that occurs in the body because of decreased
insulin activity and/or insulin secretion. Pathological changes such as nephropathy …

Abstract Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown to reduce
cardiovascular events and mortality in patients with type 2 diabetes mellitus (T2DM), but they …

Introduction: While ample evidence on improved glycemic control, weight reduction, and
lowered blood pressure (BP) with sodium-glucose cotransporter type 2 inhibitors (SGLT2is) …

Introduction Factors such as compliance, cost and safety play a major role in achieving the
long-term goal in the management of type 2 diabetes mellitus (T2DM). Dapagliflozin carries …

Background: Dapagliflozin is a sodium–glucose co transporter-2 inhibitor that proved
efficacy in reduction of blood glucose level through extrusion of glucose in urine. It is used in …

Evaluate the efficacy of dapagliflozin on glycaemic and non-glycaemic indices and assess
quality of life in type 2 diabetes patients (T2DM) with inadequate glycaemic control on three …

Objectives: To evaluate the effectiveness of adding dapagliflozin as an intensification
strategy for the treatment of patients with uncontrolled type 2 diabetes mellitus (T2DM) …

Objective: The objective was to evaluate the clinical experience and treatment patterns of
generic dapagliflozin usage in different patient profiles in Indian settings. Materials and …

Aim: To evaluate effectiveness of dapagliflozin in the management of type-2 diabetes
mellitus in combination with other OHA's and/or insulin. Material and Methods: This study …

Abstract Background & Objective: Polycystic ovary syndrome (PCO) is one of the most
common causes of infertility due to anovulatory in women. The use of insulin-sensitizing …